WASHINGTON (AP) — Federal health regulators on Tuesday signed off on the first new sunscreen ingredient for the U.S. market in more than 25 years, giving Americans access to a skin-protecting chemical long used in Europe and other parts of the world. The Food and Drug Administration says the ingredient, bemotrizinol, met the agency’s standards for protecting from dangerous ultraviolet rays while causing little irritation or absorption into the skin.
Main Idea: The FDA approved bemotrizinol, the first new U.S. sunscreen ingredient in more than 25 years, and it will first be sold by DSM Nutritional Products under the brand Parsol Shield.
Key Points:
New US sunscreen products may cost more at first while DSM Nutritional Products has 18 months of market exclusivity.
Bemotrizinol could give consumers better UVA and UVB protection with less white residue, which may improve daily sun safety.
Rate how each entity in this article affected the American people.
Named manufacturer that will initially sell the ingredient in the U.S. and has direct commercial stakes in the.
Named commercial brand under which the ingredient is expected to launch in the U.S.
Central regulator that approved the new sunscreen ingredient and is the main institutional actor in the story.
Named advocate quoted on the approval, but he is a supporting voice rather than the article’s main focus.
Advocacy group quoted supporting broader sunscreen reform and new ingredient access.
Mentioned as the body that authorized the ingredient in 1999, providing background context.
Mentioned only in the AP funding note, not as an actor in the story.
Comments here are the same thread shown when this article appears in The Pulse.
No comments on this article yet.
Sign in to commentMentioned only in the AP funding note, not as an actor in the story.